Kontakte nou
- Sal 309, Meihua Building, Taiwan Industrial Park, No.2132 Songbai Road, Bao'an District, Shenzhen, Lachin
- sales@biorunstar.com
- +86-0755 2308 4243

Beta-Amyloid (42-1), Imèn
Nimewo Katalòg: BRS16012
Nimewo CAS: 317366-82-8
Fòmil molekilè: C203H311N55O60S1
Pwa molekilè: 4514.1
Pite: Zòn pik pa HPLC Pi gran pase oswa egal a 95%
Fòm: Lyophilized
Beta-Amyloid (42-1) Imèn, sekans ranvèse A (1-42) Imèn, yo itilize kòm yon kontwòl nan rechèch maladi alzayme (AD).
Espesifikasyon
|
Sekans yon sèl lèt kòd |
AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD |
|
Sekans twa lèt kòd |
Ala-Ile-Val-Val-Gly-Gly{-Val-Met-Leu-Gly-Ile-I le-Ala-Gly{-Lys-Asn-Ser-Gly{-Val-Asp-Glu-Al a-Phe-Phe{-Val-Leu-Lys-Gln-His-Li-Val-Gl u-Tyr-Gly-Ser-Asp-Li-Arg-Phe-Glu-Ala-Asp |
|
Nimewo CAS |
317366-82-8 |
|
Fòmil molekilè |
C203H311N55O60S1 |
|
Pwa molekilè |
4514.1 |
|
Modifikasyon |
N/A |
|
Pite |
Zòn pik pa HPLC Pi gran pase oswa egal a 95% |
|
Fòm |
Liyofilize |
|
Long Depo |
- 20 degre oswa pi ba |
| Pou itilize rechèch sèlman. | |
Referans:
1. Takeda, S., et al. (2010). Neuroimaging maladi alzayme a ak "ipotèz kaskad amiloyid la."Nerobyoloji nan aje, 31(9), 1510–1517.
2. Stine, WB, Jr., et al. (2003). Karakterizasyon an vitro nan kondisyon pou oligomerizasyon amiloid-beta peptide ak fibrilojenèz.Jounal la nan chimi byolojik, 278(13).
Baj popilè: beta-amyloid (42-1), imen, beta-amyloid (42-1), founisè imen
Ou ka renmen tou










